Statistical and measurement evidence validates the comparison of the 22-item Sinonasal Outcome Test (SNOT-22) responses or scale scores before and after endoscopic sinus surgery to quantify changes in symptoms and dysfunctions in patients with chronic rhinosinusitis.
Perrigo announced that the FDA has granted final approval on its Abbreviated New Drug Application (ANDA) for Azelastine HCl Nasal Spray, the generic version of Meda’s Astepro.
Ranbaxy has announced a voluntary recall of 29,790 blister packs of an over-the-counter (OTC) allergy medication in the U.S. after an unacceptable number of blister defects were identified.
The Rhinix nasal filter seems to be beneficial for adults with allergic rhinitis, according to a newly published letter to the editor.
Allergy prevalence is uniform across varying regions in the U.S, except in children ≤5 years old, according to an NIH study.
Nasal corrective surgery prior to adolescence is safe for select pediatric patients with nasal obstruction and deformity.
For patients presenting to the emergency department with acute respiratory tract infections (ARTI), inappropriate utilization of antibiotics has decreased for children, but not for adults.
The FDA has approved Nasacort (triamcinolone acetonide; Sanofi Aventis) Allergy 24hr nasal spray as an over-the-counter (OTC) treatment for seasonal and perennial nasal allergies in adults and children 2 years of age and older.
The FDA is warning against the use of budesonide solution from The Compounding Shop due to possible contamination.
Merck’s Biologics License Application was accepted for its investigational Timothy grass pollen allergy immunotherapy tablet (AIT). In March, the company submitted a BLA for its investigational ragweed pollen AIT.
